rs2297440 — RTEL1 RTEL1 telomere maintenance variant

RTEL1 — When the Telomere Maintenance Helicase Falters

At the tips of every chromosome sit telomeres — repetitive DNA sequences that protect the genome from erosion with each cell division. Maintaining these caps requires more than the enzyme telomerase; it requires a specialized helicase called RTEL1¹¹ RTEL1
Regulator of Telomere Elongation Helicase 1 — a DNA helicase essential for resolving structural barriers that arise at telomeres during replication and repair. RTEL1 dismantles T-loops (protective hairpin structures formed at telomere ends), resolves G-quadruplex structures that form in the guanine-rich telomeric sequence, and participates broadly in genome-wide DNA repair. rs2297440 is a common intronic variant at the RTEL1 locus on chromosome 20q13.33 that has been associated with altered glioma susceptibility across multiple populations — a signal most plausibly explained by differences in telomere maintenance capacity and genomic stability.

The Mechanism

As an intronic variant, rs2297440 does not change the RTEL1 protein sequence directly. Rather, it tags a haplotype within the RTEL1 gene that may influence expression levels, splicing efficiency, or regulatory element function in specific cell types — particularly neural progenitor cells and immune cells, where telomere maintenance is critical for clonal expansion and self-renewal. RTEL1 protein is required at two distinct points during the cell cycle: it opens the T-loop to allow telomerase access for elongation, and it suppresses aberrant homologous recombination across telomeric repeats that would otherwise generate extrachromosomal telomere circles (T-circles) and drive telomere instability. Reduced RTEL1 function — even heterozygous reduction — produces measurable increases in T-circle formation²² T-circle formation
T-circles are circular telomere DNA molecules generated when the T-loop is aberrantly excised; their accumulation is a marker of telomere instability and accelerated telomere shortening and shortened peripheral blood telomere length. In the immune compartment, telomere shortening limits lymphocyte proliferative capacity and accelerates immune aging, a process implicated in inflammaging — the chronic low-grade inflammation that underlies multiple age-related diseases.

The Evidence

The chromosome 20q13.33 RTEL1 locus was first identified as a glioma susceptibility locus through European GWAS, with multiple SNPs across the locus — including rs2297440 and rs6010620 — reaching genome-wide significance. A case-control study in 629 Chinese glioma patients and 645 controls³³ case-control study in 629 Chinese glioma patients and 645 controls found rs2297440 significantly associated with glioma risk (OR 1.33, 95% CI 1.12–1.58, p=0.001); the CC genotype (homozygous for the C/non-T allele) was strongly protective (OR 0.47, 95% CI 0.31–0.71, p=0.0003), while the T allele consistently appeared at higher frequency in cases. A meta-analysis⁴⁴ meta-analysis pooling multiple case-control studies confirmed the rs2297440 T allele confers significantly elevated glioma risk across European, Asian, and American subgroups, supporting its biological rather than population-specific relevance.

Beyond glioma, the RTEL1 locus connects to pulmonary biology. A case-control study of high-altitude pulmonary edema⁵⁵ case-control study of high-altitude pulmonary edema
HAPE — a life-threatening non-inflammatory pulmonary edema triggered by hypoxic stress; SNPs in RTEL1 were associated with altered susceptibility, implicating telomere maintenance in pulmonary vascular response found RTEL1 variants associated with HAPE risk in Chinese populations. More clinically, heterozygous rare RTEL1 mutations — at the severe end of the same functional spectrum — account for approximately 6% of familial pulmonary fibrosis⁶⁶ 6% of familial pulmonary fibrosis
IPF — idiopathic pulmonary fibrosis; a progressive, fatal lung scarring disease linked to short telomeres in alveolar epithelial cells families, establishing that the RTEL1 telomere-maintenance axis is directly implicated in fibrotic pulmonary inflammation. Related RTEL1 variants (rs2297441, rs3208008) have been shown to influence both leukocyte telomere length and prostate cancer risk⁷⁷ both leukocyte telomere length and prostate cancer risk
A Chinese case-control study demonstrated that RTEL1 variants associating with shorter telomeres also associate with increased cancer susceptibility, supporting telomere length as the mechanistic intermediate, pointing to telomere length as the intermediate phenotype linking RTEL1 variation to diverse cancer and inflammatory outcomes.

Practical Actions

The T allele's risk is primarily genomic stability–mediated: reduced RTEL1 helicase efficiency allows telomere erosion in rapidly dividing cells. Supporting telomere maintenance biochemically — particularly through antioxidant pathways that reduce oxidative damage to telomere repeats — is the most actionable intervention. Folate-dependent one-carbon metabolism is directly linked to telomere maintenance: folate drives the synthesis of nucleotides needed for telomere repair, and inadequate folate status accelerates telomere shortening independently of RTEL1 function. Periodic monitoring of telomere length via clinical testing is emerging as a practical option for T-allele carriers concerned about their genomic aging trajectory.

Interactions

rs2297440 shares a haplotype block with rs6010620, which shows nearly identical associations with glioma risk in most studies (OR 1.32, 95% CI 1.11–1.56 in the same Chinese cohort). Carriers of risk alleles at both SNPs likely have the highest risk at this locus. Related variants rs2297441 and rs3208008 influence telomere length in independent analyses and may compound the effect of rs2297440 on telomere maintenance capacity. Given the biological mechanism, variants in other telomere biology genes — TERT, TERC, OBFC1 — may interact additively: polygenic telomere length scores that incorporate RTEL1 variants have been shown to associate with cancer susceptibility and longevity outcomes.